Hiroko Yoneda
Hiroko Yoneda publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Pancreatic function and diabetes.
- World rank
- #5,832,921 of 7,710,434 ranked researchers
- Rank in Japan
- #210,512 of 383,136
- Works
- 20
- Citations
- 298
- Citations per work
- 14.9
What does Hiroko Yoneda research?
Hiroko Yoneda's work is mostly in Medicine (44%), Biochemistry, Genetics and Molecular Biology (15%), Chemistry (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences944.1%
- Medicine944.1%
- Everything else632.1%
- Life Sciences315.3%
- Physical Sciences28.5%
- Chemistry15.1%
- Physics and Astronomy13.4%
- 1Endocrinology, Diabetes and Metabolism34% of their works
- 2Surgery10% of their works
- 3Molecular Biology10% of their works
- 4Genetics5% of their works
- 5Organic Chemistry5% of their works
- 6Atomic and Molecular Physics, and Optics3% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pancreatic function and diabetes
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Advanced Glycation End Products research
- Diabetes and associated disorders
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Cancer, Hypoxia, and Metabolism
Which keywords describe Hiroko Yoneda's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Diabetes, Cardiovascular Disease, Cardiovascular Outcomes, Diabetes Mellitus, Oxidative Stress and Type 1 Diabetes.
- HIF-1
- HMGB1
- Critical Care
- Advanced Glycation End Products
- Insulin Resistance
- Pancreatic Islets
- Continuous Glucose Monitoring
- Type 1 Diabetes
- Diabetes Mellitus
- Cardiovascular Disease
- Insulin Therapy
- Glycemic Control
- Diabetes
- Cardiovascular Outcomes
- Oxidative Stress
- Type 2 Diabetes
- Hypoglycemia
- ß-Cell Dysfunction
- Metabolic Syndrome
- Autoimmunity
- Genetics
- Hyperglycemia
- Warburg Effect
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Glycemic Control143 topics
- Insulin Therapy143 topics
- Diabetes113 topics
- Cardiovascular Disease92 topics
- Cardiovascular Outcomes71 topic
- Diabetes Mellitus72 topics
- Oxidative Stress72 topics
- Type 1 Diabetes72 topics
- Type 2 Diabetes71 topic
- Continuous Glucose Monitoring51 topic
- Hypoglycemia51 topic
- Pancreatic Islets51 topic
- ß-Cell Dysfunction51 topic
- Insulin Resistance41 topic
- Metabolic Syndrome41 topic
- Advanced Glycation End Products21 topic
- Autoimmunity21 topic
- Critical Care21 topic
- Genetics21 topic
- HMGB121 topic
- Hyperglycemia21 topic
- HIF-111 topic
- Warburg Effect11 topic
Where does Hiroko Yoneda work?
Hiroko Yoneda's main affiliation in the publication record is The University of Osaka, Japan.
How many publications and citations does Hiroko Yoneda have?
OpenAlex counts 20 works and 298 citations for Hiroko Yoneda, an h-index of 8, ranking #5,832,921 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hiroko Yoneda. Posts are plain text and can be reported.